Dr. Craig G. Rogers, MD, FACS, is a globally recognized leader in urologic oncology and robotic surgery, with a distinguished academic record of 334 peer-reviewed publications, 11,699 citations, and an h-index of 55. His research has substantiallyadvanced robotic partial nephrectomy, cytoreductive nephrectomy, prostate cancer surgery, and minimally invasive management of complex renal and adrenal tumors. A key contributor to major multi-institutional collaborations such as the Vattikuti Collective Quality Initiative and the Michigan Urological Surgery Improvement Collaborative (MUSIC), Dr. Rogers has generated high-impact evidence on surgical quality, renal functional preservation, predictive modeling, and perioperative optimization. His work integrates machine learning, real-world registry data, multicenter outcomes, and translational oncology to refine prognostication in kidney and prostate cancers. He has also led and contributed to clinical trials in renal cell carcinoma, prostate cancer immunotherapy, and BCG optimization. Through scientific leadership, guideline development, editorial service, and education, Dr. Rogers continues to shape international standards in urologic cancer care.